J9300 – Injection, gemtuzumab ozogamicin, 5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9300
- Long description
- Injection, gemtuzumab ozogamicin, 5 mg
- Short description
- Gemtuzumab ozogamicin inj
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- Added
- January 1, 2002
- Last change
- January 1, 2018 – No change
- Termination date
- December 31, 2017
Frequently asked questions
What is HCPCS code J9300?
J9300 is a HCPCS Level II code for injection, gemtuzumab ozogamicin, 5 mg. It was discontinued on December 31, 2017.
Does Medicare cover J9300?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9292 – Injection, pemetrexed dipotassium, 10 mg
- J9293 – Injection, mitoxantrone hydrochloride, per 5 mg
- J9294 – Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg
- J9295 – Injection, necitumumab, 1 mg
- J9296 – Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg
- J9297 – Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg
- J9298 – Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg
- J9299 – Injection, nivolumab, 1 mg
- J9301 – Injection, obinutuzumab, 10 mg
- J9302 – Injection, ofatumumab, 10 mg
- J9303 – Injection, panitumumab, 10 mg
- J9304 – Injection, pemetrexed (pemfexy), 10 mg
- J9305 – Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 – Injection, pertuzumab, 1 mg
- J9307 – Injection, pralatrexate, 1 mg
- J9308 – Injection, ramucirumab, 5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.